Global Predictive Diagnostics Market: Overview
Predictive diagnostics and personalized therapies hold great scope for modern practices in medicine. Developments in these areas have opened up new approaches in public health care system across various industrialized and emerging nations. The market for predictive diagnostics has soared in popularity in developed nations for the prevention of a host of chronic degenerative diseases. The market has evolved steadily driven by developments in novel diagnostic biomarkers for different disease states and early, targeted prevention protocols for common human pathologies.
Progress in personalized medicine has led to the discovery of optimal treatment planning methods and personalized medicines reducing the cost of healthcare delivery for a large part of population. Technological advances in molecular biology have improved our understanding of a variety of diseases. This is expected to expand the potential of predictive diagnostics in modern clinical practices worldwide. In the coming years, predictive diagnostics methodologies will become an integral part of holistic healthcare open up exciting opportunities in the market.
The report offers comprehensive insights into the major market dynamics, current trends and emerging opportunities, key screening protocols in major nations, advances in molecular medicine, and competitive landscape. The research analysis takes a closer look at recent advances in human genome and developments related to novel diagnostic biomarkers expected to create new opportunities for market players.
Global Predictive Diagnostics Market: Trends and Opportunities
The rising prevalence of chronic degenerative diseases (CDD) such cardiovascular, autoimmune, and neurodegenerative diseases and the increasing incidence of various cancer types, especially across geriatric population are the key factors stimulating the demand for predictive diagnostics. The pressing need for detection of various genetic disorders in the earliest stages has fuelled the demand for advanced predictive diagnostic technologies worldwide. Advances in genome sequencing and advancement in technologies pertaining to molecular biology are expected to boost the market. In addition, the rising global awareness of targeted treatment and prevention of a range of diseases is expected to fuel the demand for predictive diagnostics. Discovery of several diagnostic predictive instruments are anticipated to open up lucrative market avenue in the coming years.
On the downside, the paucity of expertise in predictive medicines and the limited reliability of biomarkers for common human pathologies are expected to hinder the market to an extent. In addition, the emergence of predictive genetic testing has significant ethical implications in developed nations causing considerable challenges to various stakeholders involved in the delivery of these tests. Nevertheless, constant advances in genetics, proteomics, and informatics have led to the development of effective biomarkers leading to promising opportunities for the market players. Furthermore, the design of a robust regulatory system is expected to positively impact the market.
Global Predictive Diagnostics Market: Regional Outlook
North America and Europe are prominent markets for predictive diagnostic methods and technologies. The substantial growth of the regional markets is primarily attributed to the increasing prevalence of several genetic and neurodegenerative disorders such as cystic fibrosis and Alzheimer's disease. In addition, high level of awareness among a large part of the population and the presence of vast discretionary spending in developed nations are expected to boost the regional markets.
Meanwhile, Asia Pacific is anticipated to exhibit lucrative avenues for players in the market. Growing popularity of personalized medicines, improving healthcare infrastructure, and increasing disposable incomes are the key factors fuelling the regional market.
Companies mentioned in the report
Major players operating in the predictive diagnostics market are Qiagen, Myriad Genetics, Inc., F. Hoffmann-La Roche AG, Genomic Health, Covance, Inc., Dako Denmark A/S, Epistem Ltd., BioGenex, Abbott Laboratories, and Almac Group Ltd.
Major regions analyzed under this research report are:
- North America
- Asia Pacific
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments